Evidence Based Medicine on FHIR Implementation Guide
1.0.0-ballot3 - STU 1 Ballot 3 World

Evidence Based Medicine on FHIR Implementation Guide, published by HL7 International / Clinical Decision Support. This guide is not an authorized publication; it is the continuous build for version 1.0.0-ballot3 built by the FHIR (HL7® FHIR® Standard) CI Build. This version is based on the current content of https://github.com/HL7/ebm/ and changes regularly. See the Directory of published versions

: Evidence for Results for Hypertension Control at 12 weeks in GroupAssignment: Quadpill vs. Candesartan

Page standards status: Informative

Raw xml | Download


<Evidence xmlns="http://hl7.org/fhir">
  <id value="397480"/>
  <meta>
    <versionId value="4"/>
    <lastUpdated value="2025-09-13T18:19:20.259Z"/>
  </meta>
  <language value="en"/>
  <text>
    <status value="generated"/>
    <div xmlns="http://www.w3.org/1999/xhtml"><p class="res-header-id"><b>Generated Narrative: Evidence 397480</b></p><a name="397480"> </a><a name="hc397480"> </a><div style="display: inline-block; background-color: #fbffeb; padding: 6px; margin: 4px; border: 1px solid #8da1b4; border-radius: 5px; line-height: 60%"><p style="margin-bottom: 0px">version: 4; Last updated: 2025-09-13 18:19:20+0000</p></div><p><b>url</b>: <a href="Evidence-397480.html">Evidence Evidence for Results for Hypertension Control at 12 weeks in GroupAssignment: Quadpill vs. Candesartan</a></p><p><b>identifier</b>: FEvIR Object Identifier/397480, <a href="http://terminology.hl7.org/7.5.0/NamingSystem-uri.html" title="As defined by RFC 3986 (http://www.ietf.org/rfc/rfc3986.txt)(with many schemes defined in many RFCs). For OIDs and UUIDs, use the URN form (urn:oid:(note: lowercase) and urn:uuid:). See http://www.ietf.org/rfc/rfc3001.txt and http://www.ietf.org/rfc/rfc4122.txt 

This oid is used as an identifier II.root to indicate the the extension is an absolute URI (technically, an IRI). Typically, this is used for OIDs and GUIDs. Note that when this OID is used with OIDs and GUIDs, the II.extension should start with urn:oid or urn:uuid: 

Note that this OID is created to aid with interconversion between CDA and FHIR - FHIR uses urn:ietf:rfc:3986 as equivalent to this OID. URIs as identifiers appear more commonly in FHIR.

This OID may also be used in CD.codeSystem.">Uniform Resource Identifier (URI)</a>/urn:oid:2.16.840.1.113883.4.642.40.44.22.77</p><p><b>version</b>: 1.0.0-ballot3</p><p><b>name</b>: Evidence_for_Results_for_Hypertension_Control_at_12_weeks_in_GroupAssignment_Quadpill_vs_Candesartan</p><p><b>title</b>: Evidence for Results for Hypertension Control at 12 weeks in GroupAssignment: Quadpill vs. Candesartan</p><p><b>citeAs</b>: </p><div><p>Evidence for Results for Hypertension Control at 12 weeks in GroupAssignment: Quadpill vs. Candesartan [Database Entry: FHIR Evidence Resource]. Contributors: Brian S. Alper, MD, MSPH [Authors/Creators]. In: Fast Evidence Interoperability Resources (FEvIR) Platform, FOI 397480. Revised 2025-09-13. Available at: https://fevir.net/resources/Evidence/397480. Computable resource at: https://fevir.net/resources/Evidence/397480#json.</p>
</div><p><b>status</b>: Active</p><p><b>date</b>: 2026-11-05 14:34:28+0000</p><p><b>author</b>: Brian S. Alper, MD, MSPH: </p><p><b>publisher</b>: HL7 International / Clinical Decision Support</p><p><b>contact</b>: HL7 International / Clinical Decision Support: <a href="http://www.hl7.org/Special/committees/dss">http://www.hl7.org/Special/committees/dss</a></p><p><b>copyright</b>: </p><div><p>https://creativecommons.org/licenses/by-nc-sa/4.0/</p>
</div><h3>RelatesTos</h3><table class="grid"><tr><td style="display: none">-</td><td><b>Type</b></td><td><b>Target[x]</b></td></tr><tr><td style="display: none">*</td><td><span title="Codes:{http://terminology.hl7.org/CodeSystem/artifact-relationship-type part-of}">Part Of</span></td><td><a href="Composition-375280.html">Outcome Measure Report for QUARTET USA Trial</a></td></tr></table><p><b>description</b>: </p><div><p>This Evidence Resource is referenced in an example for the EBMonFHIR Implementation Guide.</p>
</div><blockquote><p><b>variableDefinition</b></p><p><b>variableRole</b>: Population</p><p><b>observed</b>: the study group</p></blockquote><blockquote><p><b>variableDefinition</b></p><p><b>variableRole</b>: Exposure</p><p><b>observed</b>: <a href="EvidenceVariable-375183.html">GroupAssignment: Quadpill vs. Candesartan</a></p></blockquote><blockquote><p><b>variableDefinition</b></p><p><b>variableRole</b>: Outcome</p><p><b>observed</b>: <a href="EvidenceVariable-375202.html">Hypertension Control at 12 weeks</a></p></blockquote><blockquote><p><b>statistic</b></p><p><b>statisticType</b>: <span title="Codes:{https://fevir.net/sevco STATO:0000182}">odds ratio</span></p><p><b>quantity</b>: 2.85</p><h3>SampleSizes</h3><table class="grid"><tr><td style="display: none">-</td><td><b>Extension</b></td><td><b>NumberOfParticipants</b></td><td><b>KnownDataCount</b></td></tr><tr><td style="display: none">*</td><td/><td>62</td><td>53</td></tr></table><blockquote><p><b>attributeEstimate</b></p><p><b>type</b>: <span title="Codes:{https://fevir.net/sevco STATO:0000196}">confidence interval</span></p><p><b>level</b>: 0.95</p><p><b>range</b>: 0.94-8.59</p></blockquote><blockquote><p><b>attributeEstimate</b></p><p><b>type</b>: <span title="Codes:{https://fevir.net/sevco STATO:0000700}">p-value</span></p><p><b>quantity</b>: 0.063</p></blockquote></blockquote></div>
  </text>
  <url value="https://fevir.net/resources/Evidence/397480"/>
  <identifier>
    <type>
      <coding>
        <system value="http://terminology.hl7.org/CodeSystem/v2-0203"/>
        <code value="ACSN"/>
        <display value="Accession ID"/>
      </coding>
      <text value="FEvIR Object Identifier"/>
    </type>
    <system value="https://fevir.net/FOI"/>
    <value value="397480"/>
    <assigner>
      <display value="Computable Publishing LLC"/>
    </assigner>
  </identifier>
  <identifier>
    <system value="urn:ietf:rfc:3986"/>
    <value value="urn:oid:2.16.840.1.113883.4.642.40.44.22.77"/>
  </identifier>
  <version value="1.0.0-ballot3"/>
  <name
        value="Evidence_for_Results_for_Hypertension_Control_at_12_weeks_in_GroupAssignment_Quadpill_vs_Candesartan"/>
  <title
         value="Evidence for Results for Hypertension Control at 12 weeks in GroupAssignment: Quadpill vs. Candesartan"/>
  <citeAs
          value="Evidence for Results for Hypertension Control at 12 weeks in GroupAssignment: Quadpill vs. Candesartan [Database Entry: FHIR Evidence Resource]. Contributors: Brian S. Alper, MD, MSPH [Authors/Creators]. In: Fast Evidence Interoperability Resources (FEvIR) Platform, FOI 397480. Revised 2025-09-13. Available at: https://fevir.net/resources/Evidence/397480. Computable resource at: https://fevir.net/resources/Evidence/397480#json."/>
  <status value="active"/>
  <date value="2026-11-05T14:34:28+00:00"/>
  <author>
    <name value="Brian S. Alper, MD, MSPH"/>
  </author>
  <publisher value="HL7 International / Clinical Decision Support"/>
  <contact>
    <name value="HL7 International / Clinical Decision Support"/>
    <telecom>
      <system value="url"/>
      <value value="http://www.hl7.org/Special/committees/dss"/>
    </telecom>
  </contact>
  <copyright value="https://creativecommons.org/licenses/by-nc-sa/4.0/"/>
  <relatesTo>
    <type>
      <coding>
        <system
                value="http://terminology.hl7.org/CodeSystem/artifact-relationship-type"/>
        <code value="part-of"/>
        <display value="Part Of"/>
      </coding>
    </type>
    <targetReference>🔗 
      <reference value="Composition/375280"/>
      <type value="Composition"/>
      <display value="Outcome Measure Report for QUARTET USA Trial"/>
    </targetReference>
  </relatesTo>
  <description
               value="This Evidence Resource is referenced in an example for the EBMonFHIR Implementation Guide."/>
  <variableDefinition>
    <variableRole value="population"/>
    <observed>
      <display value="the study group"/>
    </observed>
  </variableDefinition>
  <variableDefinition>
    <variableRole value="exposure"/>
    <observed>🔗 
      <reference value="EvidenceVariable/375183"/>
      <type value="EvidenceVariable"/>
      <display value="GroupAssignment: Quadpill vs. Candesartan"/>
    </observed>
  </variableDefinition>
  <variableDefinition>
    <variableRole value="outcome"/>
    <observed>🔗 
      <reference value="EvidenceVariable/375202"/>
      <type value="EvidenceVariable"/>
      <display value="Hypertension Control at 12 weeks"/>
    </observed>
  </variableDefinition>
  <statistic>
    <statisticType>
      <coding>
        <system value="https://fevir.net/sevco"/>
        <code value="STATO:0000182"/>
        <display value="odds ratio"/>
      </coding>
    </statisticType>
    <quantity>
      <value value="2.85"/>
    </quantity>
    <sampleSize>
      <extension
                 url="http://hl7.org/fhir/uv/ebm/StructureDefinition/number-analyzed">
        <valueUnsignedInt value="60"/>
      </extension>
      <numberOfParticipants value="62"/>
      <knownDataCount value="53"/>
    </sampleSize>
    <attributeEstimate>
      <type>
        <coding>
          <system value="https://fevir.net/sevco"/>
          <code value="STATO:0000196"/>
          <display value="confidence interval"/>
        </coding>
      </type>
      <level value="0.95"/>
      <range>
        <low>
          <value value="0.94"/>
        </low>
        <high>
          <value value="8.59"/>
        </high>
      </range>
    </attributeEstimate>
    <attributeEstimate>
      <type>
        <coding>
          <system value="https://fevir.net/sevco"/>
          <code value="STATO:0000700"/>
          <display value="p-value"/>
        </coding>
      </type>
      <quantity>
        <value value="0.063"/>
      </quantity>
    </attributeEstimate>
  </statistic>
</Evidence>